These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20836398)

  • 21. Reply to Letter: Evaluation of macular blood flow after intermittent intravenous infusion of high-dose corticosteroids (pulse therapy) in patients with thyroid-associated orbitopathy (TAO) using angio-OCT.
    Del Noce C; Desideri LF; Roda M; Vagge A
    Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):4027. PubMed ID: 35666296
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe unilateral orbitopathy in a patient with Hashimoto's thyroiditis - a case report.
    Cyranska-Chyrek E; Olejarz M; Szczepanek-Parulska E; Stajgis P; Pioch A; Ruchala M
    BMC Ophthalmol; 2019 Jan; 19(1):9. PubMed ID: 30621642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis.
    Meringolo D; Campi I; Costante G
    Endocrine; 2018 Nov; 62(2):490-491. PubMed ID: 29987702
    [No Abstract]   [Full Text] [Related]  

  • 24. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
    Wiersinga WM
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Euthyroid Graves' disease: a case report].
    Hornez N; Morell-Dubois S; Woillez JP; Queyrel V; Charlanne H; Launay D; Lambert M; Hachulla E; Wemeau JL; Hatron PY
    Rev Med Interne; 2009 Nov; 30(11):988-90. PubMed ID: 19299047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graves' orbitopathy: Diagnosis and treatment.
    Drui D; Du Pasquier Fediaevski L; Vignal Clermont C; Daumerie C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):656-664. PubMed ID: 30177259
    [No Abstract]   [Full Text] [Related]  

  • 27. Superior ophthalmic vein thrombosis: A rare complication of Graves' orbitopathy.
    Sorrentino D; Taubenslag KJ; Bodily LM; Duncan K; Stefko T; Yu JY
    Orbit; 2018 Jun; 37(3):175-178. PubMed ID: 29053044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study.
    Salvi M; Vannucchi G; Campi I; Currò N; Dazzi D; Simonetta S; Bonara P; Rossi S; Sina C; Guastella C; Ratiglia R; Beck-Peccoz P
    Eur J Endocrinol; 2007 Jan; 156(1):33-40. PubMed ID: 17218723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the patients with Grave's ophthalmopathy after the corticosteroids treatment.
    Petrović MJ; Sarenac T; Srećković S; Petrović M; Vulović D; Janićijević K
    Vojnosanit Pregl; 2012 Mar; 69(3):249-52. PubMed ID: 22624411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endocrine orbitopathy: the present view of a clinical endocrinologist].
    Jiskra J
    Vnitr Lek; 2017; 63(10):690-696. PubMed ID: 29127744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.
    Krassas GE; Gogakos A
    J Pediatr Endocrinol Metab; 2006 Oct; 19(10):1193-206. PubMed ID: 17172081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid-Associated Orbitopathy: Management and Treatment.
    Hennein L; Robbins SL
    J Binocul Vis Ocul Motil; 2022; 72(1):32-46. PubMed ID: 34874796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thyroid associated orbitopathy: from diagnosis to treatment].
    Hamédani M; Obéric A
    Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012.
    Perros P; Žarković M; Azzolini C; Ayvaz G; Baldeschi L; Bartalena L; Boschi A; Bournaud C; Brix TH; Covelli D; Ćirić S; Daumerie C; Eckstein A; Fichter N; Führer D; Hegedüs L; Kahaly GJ; Konuk O; Lareida J; Lazarus J; Leo M; Mathiopoulou L; Menconi F; Morris D; Okosieme O; Orgiazzi J; Pitz S; Salvi M; Vardanian-Vartin C; Wiersinga W; Bernard M; Clarke L; Currò N; Dayan C; Dickinson J; Knežević M; Lane C; Marcocci C; Marinò M; Möller L; Nardi M; Neoh C; Pearce S; von Arx G; Törüner FB
    Br J Ophthalmol; 2015 Nov; 99(11):1531-5. PubMed ID: 25953846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
    Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
    Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine.
    Abraham-Nordling M; Wallin G; Träisk F; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Asman P; Lundell G; Törring O;
    Eur J Endocrinol; 2010 Oct; 163(4):651-7. PubMed ID: 20660002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.